Sunday, March 15, 2015

Europe|American and British Aid Workers Infected With Ebola in Sierra Leone

The New York TimesThe New York Times


search sponsored by

http://nyti.ms/1AoPzog


A worker from Partners In Health, the prominent American medical aid organization, and an emergency worker from the British military have been infected with the deadly Ebola virus in Sierra Leone, health officials said Thursday.
The Partners In Health worker was the first in that group to be infected since it made an ambitious commitment last fall to help combat Ebola in West Africa, and was the first American health worker in months to get the disease while working in the region. The infections of both the American and Briton served as a reminder that the scourge that has ravaged Sierra Leone, Liberia and Guinea for the past year is far from defeated, even as the number of new cases has declined drastically.
The National Institutes of Health in Bethesda, Md., said in a statement that the American had been ordered flown back to the United States in isolation on a chartered plane, to be admitted on Friday to the N.I.H. hospital in Bethesda. The statement did not identify the worker by name or affiliation, and the person’s precise condition was not known. But other officials in Sierra Leone confirmed the person had been part of a Partners In Health team caring for Ebola patients in the Port Loko district.
Continue reading the main story

Graphic

How Many Ebola Patients Have Been Treated Outside of Africa?

Questions and answers on the scale of the outbreak and the science of the Ebola virus.
OPEN Graphic
“They’ve been very great. We are saddened by the fact that one of them has been infected,” said Sidie Tunis, communications director for Sierra Leone’s National Ebola Response Center. “They helped us a lot to control the virus in Sierra Leone. It’s not a pleasant moment for us that one of them is infected.”
Partners In Health, led by Dr. Paul Farmer and Ophelia Dahl, is known for its work in impoverished countries. It opened Ebola treatment units for the first time last year, and has reported sending over 250 American health professionals. In Sierra Leone, the group joined with an existing organization, the Wellbody Alliance, to care for Ebola patients.
The N.I.H. hospital has treated one other Ebola patient: Nina Pham, a nurse infected while caring for a Liberian patient in Dallas. She recovered. Emory University Hospital in Atlanta and Nebraska Medical Center in Omaha have also successfully treated American health workers who were infected in Africa and flown back to the United States.
Earlier Thursday, British officials said a Royal Air Force plane left Sierra Leone carrying three British military health workers, of whom one had tested positive for Ebola. The other two were under observation for signs of infection, officials said. All three were taken to the Royal Free Hospital in northwest London, which has a specialized unit to treat Ebola patients.
The World Health Organization said Thursday that the number of deaths in the Ebola epidemic had surpassed 10,000. While the number of new cases has fallen in all three countries in recent months — and reached zero in Liberia last week — the transmission of the disease has been a resilient problem in the other two.

Ten Americans evacuated with Ebola fears

Ten Americans evacuated with Ebola fears

Ten health care workers who may have been exposed to Ebola in Sierra Leone are being flown to the US.
Ten American health care workers who may have been exposed to the Ebola virus in Sierra Leone are being flown to the US for monitoring.
The move comes after a US clinician with the charity Partners in Health tested positive for the deadly virus and was transferred to a hospital near Washington for treatment.
The 10 volunteers may have come into contact with the Ebola patient, and are being flown via non-commercial aircraft, the US Centres for Disease Control and Prevention said in a statement.
'CDC can confirm that 10 American health care workers who've been volunteering in Sierra Leone are returning to the US to undergo monitoring according to CDC recommendations,' spokeswoman Kathy Harben told AFP.
The CDC said it was working with the State Department to facilitate their safe return.
None of the workers have currently been identified as having the disease, the CDC noted.
The workers will remain near the University of Nebraska Medical Centre, the National Institutes of Health or Emory University Hospital, all of which are equipped to treat Ebola patients.
'Individuals will follow CDC's recommended monitoring and movement guidelines, including direct active monitoring and, as appropriate, voluntary self isolation during the 21-day incubation period,' the agency said.
Any of the workers showing Ebola symptoms will be taken to a specialised treatment centre for evaluation and care.
The patient being treated at the National Institutes of Health Clinical Centre near the US capital was listed in serious condition on Friday.
On Thursday, the World Health Organisation announced that the death toll from the world's largest Ebola outbreak had topped 10,000.
- See more at: http://www.skynews.com.au/news/world/nthamerica/2015/03/15/ten-americans-evacuated-with-ebola-fears.html#sthash.6tHdycZv.dpuf

23andMe Helps Pfizer & Others Get into the DNA Business

23andMe Helps Pfizer & Others Get into the DNA Business

Susanne.Posel-Headline.News.Official- 23andme.pfizer.genetech.fda.bloom.syndrome.designer.babies.google_occupycorporatismSusanne Posel ,Chief Editor Occupy Corporatism | The US Independent
March 13, 2015

23andMe has made their mark as the newest go-to for pharmaceutical corporations looking to get into the DNA business.
This genetic tech corporation is owned by Anne Wojcicki, estranged wife of Google founder Sergey Brin, and funded by Google and Google Ventures with an initial investment of $161 million.
The home genetics company has collaborated with Pfizer “to conduct genome-wide association studies and surveys, as well as expedite clinical trial recruitment” and the genome tech giant Genetech for a $60 million venture to “analyze whole-genome sequence data in hopes of finding new therapeutic targets for Parkinson’s disease.”
As part of the deal , 23andMe hired 14 year veteran from Gentech, Richard Schenller as their chief scientist and head of research and development.
To begin with 680,000 customers of 23andMe have agreed to let the corporation use their genetic data for research into drug therapies that can be licensed “to larger, more established drugmakers” in the future.
For research purposes, the Food and Drug Administration (FDA) agree gave their approval to use 23andMe’s home genetic testing kit (HGTK) under the condition they search for a genetic marker for Bloom Syndrome.
Bloom syndrome is an inherited disorder causing shorter and thinner stature and affects “people of Central and Eastern European (Ashkenazi) Jewish background, among whom about 1 in 50,000 are affected. Approximately one-third of people with Bloom syndrome are of Ashkenazi Jewish descent.”
This hasty decision is in direct conflict with the FDA’s stance on 23andMe’s product established in November of 2013 that their HGTK which is still under review “may not work as advertised”.
This was further clarified in a letter to 23andMe from the FDA voicing this concern: “[We are] concerned about the public health consequences of inaccurate results from the PGS device. The main purpose of compliance with FDA’s regulatory requirements is to ensure that the tests work.”
The HGTK is designed to test and diagnose mutation in the genome to determine the genetic traits possible future children will inherit from their parents.
A sample of saliva from the subject is then run through a gene chip provided by Illumina for deciphering of genetic ancestry and information on genetic risks, propensities and “mutations” that could lead to disease during the individual’s lifetime.
As part of their patented process, 23andMe has a tool called the Family Traits Inheritance Calculator (FTIC).
This “calculator” deciphers gene mutations to control certain characteristics desired by the subject for future generations; i.e. 23andMe claims to be able to make a child genetically designed by the parents.
Parents can choose to accentuate or deaccentuate genetic traits such as:
• Height
• Weigh
• Muscle development
• Athletic abilities
• Personality traits
• Development of cancer and other diseases
• Extended life span
23andMe promises: “You could say whether you want a kid with blue eyes or green eyes, a long lifespan, or less risk of colorectal cancer. Or more risk of colorectal cancer, if that’s what you’re into. The system then runs the database of your genes against others, to recommend a mating match that would be likely to produce a child with said traits.”
The patent for the FTIC would have allowed for more “calculated” donors in sperm and egg clinics that will facilitate recipients can evaluate the genetic possibilities when combined with the donor and their own.
What's Trending Online
?
X These content links are provided by Content.ad.Both Content.ad and the web site upon which the linksare displayed may receive compensation when readers click on these links. Some of thecontent you are redirected to may be sponsored content. View our privacy policyhere.

To learn how you can use Content.ad to drivevisitors to your content or add this service to your site, please contact us atinfo@content.ad.

23andMe Helps Pfizer & Others Get into the DNA Business
1 vote, 5.00 avg. rating (95% score)

CDC’s New Director of Public Health Preparedness and Response

CDC’s New Director of Public Health Preparedness and Response

CDC's OPHPR Director Stephen ReddThe Centers for Disease Control and Prevention (CDC) Office of Public Health Preparedness and Response (OPHPR) has a new director, Rear Admiral Stephen C. Redd, MD.
Dr. Redd is a Rear Admiral and Assistant to the Surgeon General in the United States Public Health Service, and has worked at CDC for nearly 30 years and served for 29 years in the U.S. Public Health Service Commissioned Corps.
Dr. Redd’s prior assignment was with the CDC’s Influenza Coordination Division.
In his new role, Dr. Redd will be leading OPHPR, which is CDC’s principle coordinator of all preparedness and response activities. PHPR provides strategic direction, support, and coordination for activities across CDC and with local, state, tribal, national, territorial, and international public health partners.
Dr. Redd joins PHPR at a critical time. CDC is running its largest international emergency response ever – the West Africa Ebola Response – as well as CDC’s global polio response.  Dr. Redd is no stranger to emergency response. He served as the CDC Incident Commander during the H1N1 response.
“Even though I have worked with PHPR for many years as director of the Influenza Coordination Division and even served as Acting Deputy Director for 3 months last year, I am still surprised with the speed and variety of work that gets done within PHPR,” said Redd.
In talking about his focus areas as the new head of OPHPR, Redd stated that the most urgent priority is to get to zero Ebola cases in West Africa.
“My second priority is measuring the impact of our programs and developing measures to assess our preparedness,” said Redd. “This type of assessment is critical as we chart our way forward and prioritize resources.”
Read more at the CDC: Introducing CDC’s New Director of Public Health Preparedness and Response.
   
- See more at: http://globalbiodefense.com/2015/03/10/cdcs-new-director-of-public-health-preparedness-and-response/#sthash.Q0h2c88H.dpuf

Mother battling circumcision now a fugitive

Contact Form

Name

Email *

Message *